Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
Ontology highlight
ABSTRACT: The risk of premature death is high among patients on haemodialysis (HD patients). We previously determined that immunoglobulin (Ig)M antibodies against phosphorylcholine (anti-PC) are negatively associated with increased risk of cardiovascular disease (CVD), atherosclerosis, some autoimmune diseases and mortality among HD patients in this cohort. Here, we also study other subclasses and isotypes of anti-PC in HD patients in relation to mortality, inflammation and gender. The study group is a cohort of 209 prevalent HD patients [median age = 66 years, interquartile range (IQR) = 51-74], vintage time = 29 months (IQR = 15-58; 56% men) with a mean follow-up period of 41 months (IQR = 20-60). Fifty-six per cent were men. We also divided patients into inflamed C-reactive protein (CRP) > 5·6 mg
SUBMITTER: Samal SK
PROVIDER: S-EPMC7290086 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA